Sodium butyrate inhibits HMGB1 expression and release and attenuates concanavalin A-induced acute liver injury in mice.
- Author:
Quan GONG
1
;
Mao-Jian CHEN
;
Chao WANG
;
Hao NIE
;
Yan-Xiang ZHANG
;
Ke-Gang SHU
;
Gang LI
Author Information
1. Department of Pathogen Biology, School of Medicine, Yangtze University, Jingzhou 434023, China. gongquan1998@163.com.
- Publication Type:Journal Article
- MeSH:
Alanine Transaminase;
metabolism;
Animals;
Aspartate Aminotransferases;
metabolism;
Butyric Acid;
pharmacology;
Chemical and Drug Induced Liver Injury;
drug therapy;
Concanavalin A;
adverse effects;
Disease Models, Animal;
HMGB1 Protein;
metabolism;
Interferon-gamma;
metabolism;
Liver;
pathology;
Mice;
Tumor Necrosis Factor-alpha;
metabolism
- From:
Acta Physiologica Sinica
2014;66(5):619-624
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of the present study is to explore the protective effects of sodium butyrate (SB) pretreatment on concanavalin A (Con A)-induced acute liver injury in mice. The model animals were first administered intraperitoneally with SB. Half an hour later, acute liver injury mouse model was established by caudal vein injection with Con A (15 mg/kg). Then, levels of serous alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured using standard clinical method by an automated chemistry analyzer, tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) were measured by ELISA, and pathological changes in hepatic tissue were observed by using HE staining and light microscopy. The expression and release of high-mobility group box 1 (HMGB1) were assessed by using reverse transcription polymerase chain reaction (RT-PCR), immunohistochemistry and ELISA. The results showed that the pretreatment of SB significantly protected Con A-treated mice from liver injury as evidenced by the decrease of serum ALT, AST (P < 0.01) and reduction of hepatic tissues necrosis. SB also decreased levels of serous TNF-α and IFN-γ (P < 0.01). Furthermore, the expression and release of HMGB1 were markedly inhibited by SB pretreatment (P < 0.05 or P < 0.01). These results suggest that the attenuating effect of SB on Con A-induced acute liver injury may be due to its role of reducing the TNF-α and IFN-γ production, and inhibiting HMGB1 expression and release.
